Be part of the knowledge.™

CME/CE

Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.

4496

LikeLikedUnlike

1-15 of 1160

CME/CE In-Person Event
Moving the Needle in oHCM: The Era of Cardiac Myosin Inhibitors
August 29, 2026
Munich
0.75 credits
CME/CE In-Person Event
Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
August 29, 2026
Munich
0.75 credits
CME/CE In-Person Event
Translating Evidence Into Practice: Myosin Inhibition Across the HCM Spectrum
August 30, 2026
Munich
0.75 credits
Advancing Treat-to-Target Care in Generalized Myasthenia Gravis: Earlier Diagnosis, Standardized Assessment, and Precision Use of FcRn-Directed Therapy
CME/CE In-Person Event
Advancing Treat-to-Target Care in Generalized Myasthenia Gravis: Earlier Diagnosis, Standardized Assessment, and Precision Use of FcRn-Directed Therapy
September 18, 2026
Palo Alto, California
1.50 credits
Advancing Treat-to-Target Care in Generalized Myasthenia Gravis: Earlier Diagnosis, Standardized Assessment, and Precision Use of FcRn-Directed Therapy
CME/CE In-Person Event
Advancing Treat-to-Target Care in Generalized Myasthenia Gravis: Earlier Diagnosis, Standardized Assessment, and Precision Use of FcRn-Directed Therapy
September 23, 2026
Chicago, Illinois
1.50 credits
CME/CE In-Person & Virtual Event
Redefining gMG Management: FcRn Antagonists and the New Era of Precision Neurology
September 30, 2026
Orlando, Florida
1.00 credits
advertisement
When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
CME/CE Virtual Event
When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
October 07, 2026
06:00 PM - 07:00 PM CEST
1.00 credits
CME/CE In-Person & Virtual Event
Unmasking HCM in Patients With Preserved EF: Diagnostic Clarity, Evolving Evidence, and Emerging Therapeutic Strategies
October 10, 2026
Multiple locations available
1.00 credits
Advancing Treat-to-Target Care in Generalized Myasthenia Gravis: Earlier Diagnosis, Standardized Assessment, and Precision Use of FcRn-Directed Therapy
CME/CE In-Person Event
Advancing Treat-to-Target Care in Generalized Myasthenia Gravis: Earlier Diagnosis, Standardized Assessment, and Precision Use of FcRn-Directed Therapy
October 10, 2026
New York, New York
1.50 credits
CME/CE In-Person & Virtual Event
From Fragmented Symptoms to Structured Care: Advancing Menopause Management in Primary Practice
October 19, 2026
Nashville, Tennessee
1.00 credits
CME/CE In-Person Event
22nd Annual Women’s Health Annual Visit (WHAV)
November 13, 2026
Pasadena, California
6.00 credits
CME/CE In-Person Event
22nd Annual Women’s Health Annual Visit (WHAV)
December 04, 2026
New York, New York
6.00 credits
advertisement
Overcoming Challenges in Transthyretin Cardiac Amyloidosis
CME/CE
Overcoming Challenges in Transthyretin Cardiac Amyloidosis
- Mathew S. Maurer, MD
- Jan M. Griffin, MD
- Frederick Ruberg, MD
1.00 credits
Mineralocorticoid Receptor Antagonists in Heart Failure: The Evolving Treatment Landscape
CME/CE
Mineralocorticoid Receptor Antagonists in Heart Failure: The Evolving Treatment Landscape
- Javed Butler, MD
- Stephen J. Greene, MD
- Muthiah Vaduganathan, MD, MPH
- Orly Vardeny, MD
1.00 credits
What You Don’t See: A Patient’s View of Living with CKD-aP
MinuteCE®
What You Don’t See: A Patient’s View of Living with CKD-aP
- Steven Fishbane, MD
- Nancy Helou, PhD
1.00 program credits

Program Chapters

Segment Chapters

Playlist:

Recommended